Mural Oncology (MURA) Projected to Post Quarterly Earnings on Tuesday

Mural Oncology (NASDAQ:MURA) is anticipated to release its earnings data before the market opens on Tuesday, March 25th. Analysts expect Mural Oncology to post earnings of ($1.98) per share for the quarter.

Mural Oncology (NASDAQ:MURA) last posted its earnings results on Tuesday, March 11th. The company reported ($2.01) earnings per share for the quarter, missing the consensus estimate of ($1.96) by ($0.05). During the same quarter in the prior year, the business posted ($3.57) EPS. On average, analysts expect Mural Oncology to post $-8 EPS for the current fiscal year and $-5 EPS for the next fiscal year.

Mural Oncology Price Performance

Mural Oncology stock opened at $4.07 on Tuesday. The firm has a 50 day simple moving average of $3.88 and a 200-day simple moving average of $3.60. The stock has a market cap of $70.12 million, a price-to-earnings ratio of -0.45 and a beta of 3.66. Mural Oncology has a 1-year low of $2.87 and a 1-year high of $5.12.

Analyst Ratings Changes

Separately, HC Wainwright reiterated a “buy” rating and issued a $18.00 price objective on shares of Mural Oncology in a research report on Wednesday, March 12th.

Mural Oncology Company Profile

Mural Oncology plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab.